Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (381-390 of 457) with videos related to

Pageof 46
Sort By:
JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
SINGLE CELL DISSECTION OF DEVELOPMENTAL ORIGINS AND TRANSCRIPTIONAL HETEROGENEITY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAIlaria Iacobucci, Andy G X Zeng, Qingsong Gao, et al.
Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2009
Outcome of transplantation for myelofibrosisKaren K Ballen, Smriti Shrestha, Kathleen A Sobocinski, et al.
Cancer Discovery|October 31, 2012
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemiaHuimin Geng, Sarah Brennan, Thomas A Milne, et al.
Blood Cancer Journal|October 23, 2021
Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengthsAbhishek A Mangaonkar, Alejandro Ferrer, Filippo Pinto E Vairo, et al.
Cell Genomics|December 20, 2023
Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulatorsKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Blood Cancer Journal|April 6, 2026
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patientsSaubia Fathima, Lior Rokach, Nour Ghosoun, et al.
Blood Advances|April 25, 2018
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohortMaximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
Mayo Clinic Proceedings|June 6, 2018
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical InformationAyalew Tefferi, Naseema Gangat, Mythri Mudireddy, et al.
Pageof 46

Showing results (381-390 of 457) with videos related to

Sort By:
Pageof 46
JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
SINGLE CELL DISSECTION OF DEVELOPMENTAL ORIGINS AND TRANSCRIPTIONAL HETEROGENEITY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAIlaria Iacobucci, Andy G X Zeng, Qingsong Gao, et al.
Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 3, 2009
Outcome of transplantation for myelofibrosisKaren K Ballen, Smriti Shrestha, Kathleen A Sobocinski, et al.
Cancer Discovery|October 31, 2012
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemiaHuimin Geng, Sarah Brennan, Thomas A Milne, et al.
Blood Cancer Journal|October 23, 2021
Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengthsAbhishek A Mangaonkar, Alejandro Ferrer, Filippo Pinto E Vairo, et al.
Cell Genomics|December 20, 2023
Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulatorsKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Blood Cancer Journal|April 6, 2026
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patientsSaubia Fathima, Lior Rokach, Nour Ghosoun, et al.
Blood Advances|April 25, 2018
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohortMaximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
Mayo Clinic Proceedings|June 6, 2018
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical InformationAyalew Tefferi, Naseema Gangat, Mythri Mudireddy, et al.
Pageof 46